山東未(wei)(wei)名生物醫(yi)(yi)藥(yao)股(gu)份有限公司(si)(以下簡稱“未(wei)(wei)名醫(yi)(yi)藥(yao)”或“公司(si)”)是未(wei)(wei)名集團控(kong)股(gu)的在深圳證(zheng)券(quan)交易所上市的A股(gu)公眾公司(si),證(zheng)券(quan)簡稱:未(wei)(wei)名醫(yi)(yi)藥(yao),證(zheng)券(quan)代碼(ma):002581。公司(si)于2015年10月19日經重大資產重組原“淄(zi)博萬(wan)昌科(ke)技(ji)股份有(you)(you)限公(gong)(gong)司(si)”更名(ming)而成。公(gong)(gong)司(si)擁有(you)(you)未名(ming)生(sheng)(sheng)物(wu)(wu)醫藥(yao)有(you)(you)限公(gong)(gong)司(si)(廈門)、天(tian)津(jin)未名(ming)生(sheng)(sheng)物(wu)(wu)醫藥(yao)有(you)(you)限公(gong)(gong)司(si)、北京(jing)科(ke)興生(sheng)(sheng)物(wu)(wu)制(zhi)品有(you)(you)限公(gong)(gong)司(si)、山東未名(ming)天(tian)源(yuan)生(sheng)(sheng)物(wu)(wu)科(ke)技(ji)有(you)(you)限公(gong)(gong)司(si)、北京(jing)未名(ming)西(xi)大(da)生(sheng)(sheng)物(wu)(wu)科(ke)技(ji)有(you)(you)限公(gong)(gong)司(si)、合肥北大(da)未名(ming)生(sheng)(sheng)物(wu)(wu)制(zhi)藥(yao)有(you)(you)限公(gong)(gong)司(si)等(deng)下屬企業或生(sheng)(sheng)產基地。
未(wei)名集(ji)團(tuan)三(san)大(da)夢想之一是“解決(jue)中國(guo)健(jian)康(kang)問題”:通過(guo)發(fa)展(zhan)生(sheng)物(wu)醫(yi)(yi)(yi)藥(yao)(yao)(yao)產(chan)業(ye),建(jian)立健(jian)康(kang)產(chan)品(pin)供給體系(xi)(xi)(xi)(xi);通過(guo)發(fa)展(zhan)現代中醫(yi)(yi)(yi)藥(yao)(yao)(yao),建(jian)立中國(guo)特色的(de)健(jian)康(kang)服務體系(xi)(xi)(xi)(xi);通過(guo)實(shi)施GHP計劃(hua),建(jian)立生(sheng)命健(jian)康(kang)管(guan)理體系(xi)(xi)(xi)(xi)。未(wei)名醫(yi)(yi)(yi)藥(yao)(yao)(yao)將發(fa)展(zhan)藥(yao)(yao)(yao)物(wu)制造(zao)、新藥(yao)(yao)(yao)研發(fa)、產(chan)品(pin)配送三(san)大(da)系(xi)(xi)(xi)(xi)統,建(jian)成(cheng)完善的(de)健(jian)康(kang)產(chan)品(pin)供給體系(xi)(xi)(xi)(xi),通過(guo)實(shi)施“百千(qian)萬億工(gong)程”,到2030年實(shi)現以下目標(biao):未(wei)名醫(yi)(yi)(yi)藥(yao)(yao)(yao)占中國(guo)醫(yi)(yi)(yi)藥(yao)(yao)(yao)市(shi)場總銷售(shou)額的(de)10%、占生(sheng)物(wu)醫(yi)(yi)(yi)藥(yao)(yao)(yao)市(shi)場總銷售(shou)的(de)50%、上(shang)市(shi)公司(si)(002581)市(shi)值超過(guo)一萬億;通過(guo)建(jian)立新藥(yao)(yao)(yao)高速(su)公路,未(wei)名醫(yi)(yi)(yi)藥(yao)(yao)(yao)將每年獲(huo)得25張新藥(yao)(yao)(yao)證書;通過(guo)國(guo)際化(hua)的(de)企(qi)業(ye)重組并購,未(wei)名醫(yi)(yi)(yi)藥(yao)(yao)(yao)成(cheng)為世界上(shang)較(jiao)大(da)的(de)醫(yi)(yi)(yi)藥(yao)(yao)(yao)企(qi)業(ye)集(ji)團(tuan)。